Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.

Lorente, J A; Valenzuela, H; Morote, J; Gelabert, A

Lorente, J A; Valenzuela, H; Morote, J; Gelabert, A.

Affiliation

Lorente JA; Department of Urology, Hospital del Mar, Autonomous University of Barcelona, Barcelona, Spain.

Eur J Nucl Med ; 26(6): 625-32, 1999 Jun.

Article in En | MEDLINE | ID: mdl-10369948

Subject(s)

Alkaline Phosphatase/blood; Biomarkers, Tumor/blood; Prostate-Specific Antigen/blood; Prostatic Neoplasms/blood; Aged; Bone Neoplasms/diagnostic imaging; Bone Neoplasms/epidemiology; Bone Neoplasms/secondary; Humans; Logistic Models; Male; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms/pathology; ROC Curve; Radionuclide Imaging

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers, Tumor / Prostate-Specific Antigen / Alkaline Phosphatase Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Eur J Nucl Med Year: 1999 Document type: Article

Search on Google

XML

PubMed Links